Download PDF
Semin Neurol 2018; 38(03): 371-378
DOI: 10.1055/s-0038-1660476
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Imaging in Autoimmune Neurology

Jenny J. Linnoila
1   Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts
› Author Affiliations
Further Information

Publication History

Publication Date:
16 July 2018 (online)

    Permissions and Reprints

Abstract

Autoimmune disorders are becoming increasingly recognized within the broader field of neurology. The discovery of multiple, novel, neutrally targeted autoantibodies over the past decade and their translation into commercially available testing, in particular, has aided in the more rapid diagnosis of these disorders. When considering imaging in autoimmune neurologic disorders, it is important, when possible, to visualize the autoimmune process itself, as well as to make sure that the patient does not have an associated malignancy driving the overall process. Positron emission tomographic scans can aid in the detection of small tumors with limited spread, as well as in the visualization of autoimmune processes affecting the brain and/or spinal cord. In autoimmune disorders of the central nervous system, imaging abnormalities can appear within the limbic system, extralimbic areas, and spinal cord. Such imaging abnormalities can serve as objective markers to follow over time to assess patients' responses to treatment. It is important to recognize that overlapping syndromes (for instance, both demyelinating and autoimmune or both infectious and autoimmune) exist and that inflammatory disorders can leave behind sequelae that can be recognized on subsequent imaging. Work is currently underway to develop more specific imaging techniques for autoimmune neurologic disorders.

Keywords

imaging - paraneoplastic - autoimmune - encephalitis - spinal cord
 

  • References

  • 1 Gorman MP. Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome. Curr Opin Pediatr 2010; 22 (06) 745-750
    CrossrefPubMedGoogle Scholar
  • 2 Titulaer MJ, McCracken L, Gabilondo I. , et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12 (02) 157-165
    CrossrefPubMedGoogle Scholar
  • 3 Linnoila J, Pittock SJ. Autoantibody-associated central nervous system neurologic disorders. Semin Neurol 2016; 36 (04) 382-396
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003; 349 (16) 1543-1554
    CrossrefPubMedGoogle Scholar
  • 5 Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 2004; 56 (05) 715-719
    CrossrefPubMedGoogle Scholar
  • 6 McKeon A, Apiwattanakul M, Lachance DH. , et al. Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. Arch Neurol 2010; 67 (03) 322-329
    CrossrefPubMedGoogle Scholar
  • 7 Armangue T, Moris G, Cantarín-Extremera V. , et al; Spanish Prospective Multicentric Study of Autoimmunity in Herpes Simplex Encephalitis. Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology 2015; 85 (20) 1736-1743
    CrossrefPubMedGoogle Scholar
  • 8 Geschwind MD, Tan KM, Lennon VA. , et al. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol 2008; 65 (10) 1341-1346
    Google Scholar
  • 9 Graus F, Titulaer MJ, Balu R. , et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016; 15 (04) 391-404
    CrossrefPubMedGoogle Scholar
  • 10 Moscato EH, Peng X, Jain A, Parsons TD, Dalmau J, Balice-Gordon RJ. Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2014; 76 (01) 108-119
    CrossrefPubMedGoogle Scholar
  • 11 Probasco JC, Solnes L, Nalluri A. , et al. Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 2017; 4 (04) e352
    CrossrefPubMedGoogle Scholar
  • 12 American College of Radiology Radiation Dose Chart. Available at: https://www.acr.org/Quality-Safety/eNews/Issue-11-September-2015/Radiation-Dose-Chart . Accessed May 15, 2018
    PubMedGoogle Scholar
  • 13 Leypoldt F, Buchert R, Kleiter I. , et al. Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry 2012; 83 (07) 681-686
    CrossrefPubMedGoogle Scholar
  • 14 Mustafa M, Levin J, Schöberl F, Rominger A. Postinfectious opsoclonus-myoclonus syndrome in a 41-year-old patient-visualizing hyperactivation in deep cerebellar nuclei by cerebral [(18) F]-FDG-PET. J Neuroimaging 2015; 25 (04) 683-685
    CrossrefPubMedGoogle Scholar
  • 15 Doherty L, Gold D, Solnes L, Probasco J, Venkatesan A. Anti-DPPX encephalitis: prominent nystagmus reflected by extraocular muscle FDG-PET avidity. Neurol Neuroimmunol Neuroinflamm 2017; 4 (04) e361
    CrossrefPubMedGoogle Scholar
  • 16 O'Toole O, Murphy R, Tracy JA, McKeon A. Teaching NeuroImages: PET-CT hypermetabolism paralleling muscle hyperactivity in stiff-person syndrome. Neurology 2013; 80 (10) e109
    CrossrefPubMedGoogle Scholar
  • 17 Flanagan EP, Kotsenas AL, Britton JW. , et al. Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures. Neurol Neuroimmunol Neuroinflamm 2015; 2 (06) e161
    CrossrefPubMedGoogle Scholar
  • 18 McKeon A, Ahlskog JE, Britton JW, Lennon VA, Pittock SJ. Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images. Arch Neurol 2009; 66 (02) 268-271
    PubMedGoogle Scholar
  • 19 Heine J, Prüss H, Bartsch T, Ploner CJ, Paul F, Finke C. Imaging of autoimmune encephalitis--relevance for clinical practice and hippocampal function. Neuroscience 2015; 309: 68-83
    CrossrefPubMedGoogle Scholar
  • 20 Dalmau J, Graus F, Villarejo A. , et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain 2004; 127 (Pt 8): 1831-1844
    CrossrefPubMedGoogle Scholar
  • 21 Kim H, Lim Y, Kim KK. Anti-ri-antibody-associated paraneoplastic syndrome in a man with breast cancer showing a reversible pontine lesion on MRI. J Clin Neurol 2009; 5 (03) 151-152
    CrossrefPubMedGoogle Scholar
  • 22 Apiwattanakul M, Popescu BF, Matiello M. , et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol 2010; 68 (05) 757-761
    CrossrefPubMedGoogle Scholar
  • 23 Kim W, Kim SH, Huh SY, Kim HJ. Brain abnormalities in neuromyelitis optica spectrum disorder. Mult Scler Int 2012; 2012: 735486
    PubMedGoogle Scholar
  • 24 Tobin WO, Guo Y, Krecke KN. , et al. Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain 2017; 140 (09) 2415-2425
    CrossrefPubMedGoogle Scholar
  • 25 Flanagan EP, Hinson SR, Lennon VA. , et al. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol 2017; 81 (02) 298-309
    CrossrefPubMedGoogle Scholar
  • 26 Flanagan EP, McKeon A, Lennon VA. , et al. Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology 2011; 76 (24) 2089-2095
    CrossrefPubMedGoogle Scholar
  • 27 Huang JF, Aksamit AJ, Staff NP. MRI and PET imaging discordance in neurosarcoidosis. Neurology 2012; 79 (10) 1070
    CrossrefPubMedGoogle Scholar
  • 28 Flanagan EP, Kaufmann TJ, Krecke KN. , et al. Discriminating long myelitis of neuromyelitis optica from sarcoidosis. Ann Neurol 2016; 79 (03) 437-447
    CrossrefPubMedGoogle Scholar
  • 29 Zalewski NL, Krecke KN, Weinshenker BG. , et al. Central canal enhancement and the trident sign in spinal cord sarcoidosis. Neurology 2016; 87 (07) 743-744
    CrossrefPubMedGoogle Scholar
  • 30 Flanagan EP. Autoimmune myelopathies. Handb Clin Neurol 2016; 133: 327-351
    PubMedGoogle Scholar
  • 31 Titulaer MJ, Höftberger R, Iizuka T. , et al. Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2014; 75 (03) 411-428
    CrossrefPubMedGoogle Scholar
  • 32 Schäbitz WR, Rogalewski A, Hagemeister C, Bien CG. VZV brainstem encephalitis triggers NMDA receptor immunoreaction. Neurology 2014; 83 (24) 2309-2311
    CrossrefPubMedGoogle Scholar
  • 33 Linnoila JJ, Binnicker MJ, Majed M, Klein CJ, McKeon A. CSF herpes virus and autoantibody profiles in the evaluation of encephalitis. Neurol Neuroimmunol Neuroinflamm 2016; 3 (04) e245
    CrossrefPubMedGoogle Scholar
  • 34 Urbach H, Soeder BM, Jeub M, Klockgether T, Meyer B, Bien CG. Serial MRI of limbic encephalitis. Neuroradiology 2006; 48 (06) 380-386
    CrossrefPubMedGoogle Scholar
  • 35 Hoffmann LA, Jarius S, Pellkofer HL. , et al. Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychiatry 2008; 79 (07) 767-773
    CrossrefPubMedGoogle Scholar
  • 36 Jones AL, Flanagan EP, Pittock SJ. , et al. Responses to and outcomes of treatment of autoimmune cerebellar ataxia in adults. JAMA Neurol 2015; 72 (11) 1304-1312
    CrossrefPubMedGoogle Scholar